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ABSTRACT 
 
As I compress on the canvas of a few pages here major results of my research on the 
retinoblastoma tumor suppressor protein (RB) spreading over the past 15 years, an 
exciting picture emerges on this unique host molecule which surpasses in its 
complexity even that of the most capable viral proteins known to date. Accordingly, 
RB has the potential to bind not only growth-promoting proteins such as insulin, but 
also to attach itself to calcium and oxygen, as well as to be secreted into the 
extracellular environment. Moreover, RB may exert proteolytic, antimicrobial and 
anti-aging activities. These condensed structure-based insights on RB are the 
substance of a scientific revolution I have initiated a long time ago, yet likely to gain 
even further speed in the years to come, thus expanding both our understanding of 
life at the molecular level and the possibilities for pharmacological modulation of 
fundamental biological phenomena, particularly in oncology and gerontology. 
 
 
 
A brief perspective on planet RB 
 
I summarize here the amino acid motifs I have discovered in the crucial tumor 
suppressor retinoblastoma protein (RB) since 1992, suggesting that RB "mirrors" the 
biochemical world in that it is considerably more versatile than previously suspected, 
thus resembling a planet with numerous interesting peaks and valleys serving as 
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docking sites for other molecules physically interacting with it or for its self-
association.  The following table gives an overview of my findings. 
 
Human RB residue number Putative or proven roleRef. 
1-26 signal peptide1 
3-5 antineoplastic & anti-aging through block 
of insulin binding to its receptor2 
13-18 amyloidogenic hexa-alanine counteracting 
(prion-associated) neurodegeneration3,4 
30-36 calcium binding site5 
142-145 IgG1 constant region-like fragment6 
148-152 oxygen-mimicking peptide7 
254-257 ß-endorphin COOH-terminus-like8 
276-280 LXCXE-like anti-apoptotic cell survival 
amino acid motif9 
649-654 insulin-binding and thus antineoplastic10-23 
as well as anti-aging24-25; furthermore, 
antimicrobial6 & anti-inflammatory6 
673-678 insulin-degrading enzyme (IDE) zinc 
binding site-like sequence26 
675-678 oxygen binding site27 
His673, Asp718 & Ser811 serine protease catalytic triad-like28 
  
Last but not least, I have unveiled that RB contains 10 potential glycosylation 
sites (29) consistent with its previously proposed roles in the extracellular 
environment (30). This plethora of anticipated functions underscores that RB is an 
unique protein that remains to be further explored along these lines and beyond. 
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